- Home
- NVCR vs WINA Comparison
NVCR vs WINA Comparison
Compare NVCR & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- WINA
- Stock Information
- Founded
- NVCR 2000
- WINA 1988
- Country
- NVCR Switzerland
- WINA United States
- Employees
- NVCR N/A
- WINA N/A
- Industry
- NVCR Medical/Dental Instruments
- WINA Other Specialty Stores
- Sector
- NVCR Health Care
- WINA Consumer Discretionary
- Exchange
- NVCR Nasdaq
- WINA Nasdaq
- Market Cap
- NVCR 1.4B
- WINA 1.4B
- IPO Year
- NVCR 2015
- WINA 1993
- Fundamental
- Price
- NVCR $12.15
- WINA $488.95
- Analyst Decision
- NVCR Buy
- WINA
- Analyst Count
- NVCR 7
- WINA 0
- Target Price
- NVCR $28.79
- WINA N/A
- AVG Volume (30 Days)
- NVCR 1.3M
- WINA 76.9K
- Earning Date
- NVCR 10-29-2025
- WINA 10-15-2025
- Dividend Yield
- NVCR N/A
- WINA 2.21%
- EPS Growth
- NVCR N/A
- WINA 2.48
- EPS
- NVCR N/A
- WINA 11.23
- Revenue
- NVCR $630,160,000.00
- WINA $83,395,300.00
- Revenue This Year
- NVCR $6.68
- WINA $6.56
- Revenue Next Year
- NVCR $7.01
- WINA $3.61
- P/E Ratio
- NVCR N/A
- WINA $45.77
- Revenue Growth
- NVCR 14.58
- WINA 0.98
- 52 Week Low
- NVCR $10.87
- WINA $295.79
- 52 Week High
- NVCR $34.13
- WINA $518.48
- Technical
- Relative Strength Index (RSI)
- NVCR 46.57
- WINA 64.85
- Support Level
- NVCR $11.98
- WINA $465.61
- Resistance Level
- NVCR $12.83
- WINA $518.48
- Average True Range (ATR)
- NVCR 0.56
- WINA 16.48
- MACD
- NVCR 0.15
- WINA 2.20
- Stochastic Oscillator
- NVCR 25.49
- WINA 59.65
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About WINA Winmark Corporation
Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.